Status:

UNKNOWN

Immunologic Responses to Single and Double Doses of COVID-19 Vaccines in Egyptians

Lead Sponsor:

Assiut University

Conditions:

COVID-19 Vaccines

Eligibility:

All Genders

25-65 years

Brief Summary

The recent Coronavirus Disease 2019 (COVID-19), has caused a global pandemic, and development of safe, effective vaccines is mandatory to return back to pre pandemic life. Many vaccines have been deve...

Eligibility Criteria

Inclusion

  • healthy adults receiving COVID-19 vaccines

Exclusion

  • any contraindication of each COVID-19 vaccine as listed by WHO

Key Trial Info

Start Date :

January 15 2021

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

August 1 2021

Estimated Enrollment :

100 Patients enrolled

Trial Details

Trial ID

NCT04706143

Start Date

January 15 2021

End Date

August 1 2021

Last Update

January 14 2021

Active Locations (0)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 0 (0 locations)

No Results Found

We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.

Immunologic Responses to Single and Double Doses of COVID-19 Vaccines in Egyptians | DecenTrialz